Sleep Intervention for Chronic Insomnia Using Virtual Reality Pilot Study
NCT: NCT04253691 · ACTIVE_NOT_RECRUITING
Brief Summary
Sleep disturbances are common among chronic pain patients, with reports typically ranging from 50-70% of patients reporting sleep difficulties. It is well documented that, alongside a high comorbidity with chronic pain, chronic insomnia also has high comorbidity with, and is a risk factor for, developing an anxiety disorders. This clinical trial will examine the effects of virtual reality (VR) meditation environments on patients with pain- and insomnia-related anxiety. The purpose of this study is to examine the benefits of using VR meditation with patients with chronic pain and chronic sleep disturbance so that clinicians can more effectively treat core causes to symptoms and reduce counterproductive therapies. Research objectives include: 1. To examine the clinical and health characteristics, including sleep, pain, fatigue, cognitive abilities, and cardiovascular health in patients with chronic pain. 2. To examine changes in the primary clinical outcomes, including chronic pain, complaints of poor sleep, and fatigue. 3. To examine changes in the secondary clinical outcomes, including mood, daytime functioning, cognitive functioning, and cardiovascular health. 4. To examine the mechanistic variables, including arousal (heart rate variability, HRV) and CS (thermal response).
Frequently Asked Questions
What is Sleep Intervention for Chronic Insomnia Using Virtual Reality Pilot Study?
Sleep Intervention for Chronic Insomnia Using Virtual Reality Pilot Study is a clinical trial registered under NCT04253691. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04253691?
The current status of NCT04253691 (Sleep Intervention for Chronic Insomnia Using Virtual Reality Pilot Study) is: ACTIVE_NOT_RECRUITING.
When did Sleep Intervention for Chronic Insomnia Using Virtual Reality Pilot Study start?
Sleep Intervention for Chronic Insomnia Using Virtual Reality Pilot Study started on 2020-02-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.